Open Banking and APIS: Revolutionizing Financial Data Access and Innovation in the U.S. Financial Sector
International Journal of Enhanced Research in Science, Technology & Engineering · 2024
DOI: 10.55948/ijerste.2024.0103 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Enhanced Research in Science, Technology & Engineering, 2024. Verfasst von Rakesh Kopperapu.
Abstract (Originalsprache)
The research reviews the transformative potential of the services on offer in the Open Banking initiative in the U.S. market through increased consumer access to data, innovation, and competition that APIs make possible. It also ascertains challenges presented by fragmented regulatory frameworks but reviews international models for actionable insight. This emphasis on standardization could help spur innovation, financial inclusions, and strong consumer protection for the country in case the regulator’s approach has such discrepancies. Cohesive policies, secure interoperability, and the key findings unleashing benefits of open banking towards advanced development in the financial ecosystem can appear. Future directions emphasize collaboration for Global Best Practices to make sustainable adoption certain.
Zitieren
APA
Kopperapu, R. (2024). Open Banking and APIS: Revolutionizing Financial Data Access and Innovation in the U.S. Financial Sector. International Journal of Enhanced Research in Science, Technology & Engineering. https://doi.org/10.55948/ijerste.2024.0103
Vancouver
Kopperapu R. Open Banking and APIS: Revolutionizing Financial Data Access and Innovation in the U.S. Financial Sector. International Journal of Enhanced Research in Science, Technology & Engineering. 2024. doi:10.55948/ijerste.2024.0103
BibTeX
@article{Kopperapu2024,
author = {Kopperapu, Rakesh},
title = {Open Banking and APIS: Revolutionizing Financial Data Access and Innovation in the U.S. Financial Sector},
journal = {International Journal of Enhanced Research in Science, Technology & Engineering},
year = {2024},
doi = {10.55948/ijerste.2024.0103}
}
EUVIMED